Comparison of postoperative complications, mortality and postoperative interventions among patients with severe cholecystitis who underwent LC and LSC
| Complication or intervention | No. (%) of patients; study group | ||
|---|---|---|---|
| LC (n = 105) | LSC (n = 46) | RR (95% CI) | |
| Postoperative complications | |||
| Bile duct injury | 4 (3.8) | 0 | 0.3 (0.01–4.6) |
| Bile leak | 4 (3.8) | 6 (13.0) | 3.4 (1.01–11.5) |
| Subphrenic collection | 7 (6.7) | 10 (21.7) | 3.1 (1.3–8.0) |
| Retained CBD stones | 5 (4.8) | 2 (4.3) | 0.9 (0.2–4.5) |
| Wound infections | 3 (2.9) | 0 | 0.3 (0.02–6.1) |
| Mortality | 2 (1.9) | 0 | 0.5 (0.02–9.2) |
| Total | 25 (23.8) | 18 (39.1) | 1.6 (0.99–2.7) |
| Postoperative interventions | |||
| Postoperative ERCP | 5 (4.8) | 7 (15.2) | 3.2 (1.1–9.5) |
| Biliary stent insertion | 3 (2.9) | 6 (13.0) | 4.6 (1.2–17.5) |
| Percutaneous drain insertion | 7 (6.7) | 7 (15.2) | 2.3 (0.8–6.1) |
| Reoperation | 4 (3.8) | 2 (4.3) | 1.1 (0.2–6.0) |
| Total | 19 (18.1) | 22 (47.8) | 2.6 (1.6–4.4) |
CBD = common bile duct; CI = confidence interval; ERCP = endoscopic retrograde cholangiopancreatography; LC = laparoscopic cholecystectomy; LSC = laparoscopic subtotal cholecystectomy; RR = relative risk.